1995
DOI: 10.1038/nbt1195-1142c
|View full text |Cite
|
Sign up to set email alerts
|

Erratum

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2003
2003
2020
2020

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 0 publications
0
6
0
Order By: Relevance
“…Recombinant A␤(1-42) purification methods described so far are complicated [18], end with A␤(1-42) fusion proteins [19] or only parts of A␤(1-42) are expressed and purified [20].…”
Section: Resultsmentioning
confidence: 99%
“…Recombinant A␤(1-42) purification methods described so far are complicated [18], end with A␤(1-42) fusion proteins [19] or only parts of A␤(1-42) are expressed and purified [20].…”
Section: Resultsmentioning
confidence: 99%
“…The methionine is oxidised during the production of the monomeric peptide but maintains similar properties to the non-oxidised Ab 42 . 54 A single 35Mox Ab 42 protofilament consists of two b-sheets (b1 and b2) that run along the fibril axis forming a parallel b-sandwich stabilized by inter-bsheet side-chain interactions. Residues 17-26 define sheet b1 and residues 31-42 form sheet b2 with a connecting loop containing residues 27-30.…”
Section: The Amyloid-b Peptide and Plaquesmentioning
confidence: 99%
“…The methionine is oxidised during the production of the monomeric peptide but maintains similar properties to the non-oxidised Ab 42 . 54 the side-chains of residues Asp23 and Lys28. Residue Lys28 also forms close contacts with residues Ile32 and Leu34 of b2.…”
Section: The Amyloid-b Peptide and Plaquesmentioning
confidence: 99%
“…The rest was noncleaved fusion protein still containing the histidine tail and the NANP-repeat sequence. [8] Transfer of the Amyloid Peptide into a Physiological Buffer…”
Section: Next Challenge: Purification Of Insoluble Protein Constructsmentioning
confidence: 99%
“…The entire procedure comprised four columns: a first Ni-NTA column to purify the fusion protein, a C18-HPLC column for CNBr cleavage, a sulfopropyl column to transfer the peptide from an acidic milieu to a neutral milieu and a second Ni-NTA column to remove the fusion protein. [8] The sulfopropyl and the Ni-NTA columns were operated in a tandem configuration where the Ni-NTA acted more like a filter by allowing the peptide to pass quickly but retaining the fusion protein. This allowed the procedure to be accomplished within minutes.…”
Section: Next Challenge: Purification Of Insoluble Protein Constructsmentioning
confidence: 99%